- Início
- Euronext Bruxelas
- Company regulated news
- Archive
- Company press releases
Company press releases
Released | Company | Title | Industry | Topic |
---|---|---|---|---|
14 Mar 2024 07:00 CET |
HYLORIS | Hyloris Présente ses Résultats Annuels pour 2023 et ses Perspectives | 20103010 Biotechnology | Income |
14 Mar 2024 07:00 CET |
ION BEAM APPLICATIONS | PanTera signs a second agreement for the supply of actinium-225 | 20102010 Medical Equipment | News contracts |
14 Mar 2024 07:00 CET |
HYLORIS | Hyloris Reports Full Year Results for 2023 & Provides Business Outlook | 20103010 Biotechnology | Income |
14 Mar 2024 06:59 CET |
HYLORIS | Communiqué à la requête de la FSMA sur les transactions avec QliniQ | 20103010 Biotechnology | Other financial transaction |
14 Mar 2024 06:59 CET |
HYLORIS | Communication at the request of the FSMA on the transactions with Qliniq | 20103010 Biotechnology | Other financial transaction |
13 Mar 2024 19:00 CET |
INTERVEST OFF-WARE | Intervest Offices & Warehouses SA: Communiqué de presse – Persbericht - Press release: a change in the composition of the Supervisory Board | 35102030 Office REITs | Corporate life |
13 Mar 2024 19:00 CET |
OXURION | Oxurion Receives Transparency Notification from Atlas Special Opportunities LLC | 20103010 Biotechnology | - |
13 Mar 2024 19:00 CET |
INTERVEST OFF-WARE | Intervest Offices & Warehouses NV: Persbericht – Communiqué de presse – Press release: a change in the composition of the Supervisory Board | 35102030 Office REITs | Corporate life |
13 Mar 2024 19:00 CET |
INTERVEST OFF-WARE | Intervest Offices & Warehouses NV: Press release – Persbericht – Communiqué de presse: a change in the composition of the Supervisory Board | 35102030 Office REITs | Corporate life |
13 Mar 2024 18:30 CET |
EVS BROADC.EQUIPM. | PUBLICATION RELATIVE À UNE NOTIFICATION DE TRANSPARENCE | 15101010 Telecommunications Equipment | Corporate life |
13 Mar 2024 18:30 CET |
EVS BROADC.EQUIPM. | PUBLICATION OF A TRANSPARENCY NOTIFICATION | 15101010 Telecommunications Equipment | Corporate life |
13 Mar 2024 12:15 CET |
AGEAS | Ageas SA/NV confirms improved possible offer for Direct Line Insurance Group Plc (Nederlandse versie volgt later) | 30301010 Life Insurance | - |
13 Mar 2024 12:15 CET |
AGEAS | Ageas SA/NV confirms improved possible offer for Direct Line Insurance Group Plc | 30301010 Life Insurance | - |
13 Mar 2024 12:15 CET |
AGEAS | Ageas SA/NV confirms improved possible offer for Direct Line Insurance Group Plc (La version française suivra) | 30301010 Life Insurance | - |
13 Mar 2024 10:04 CET |
AGFA-GEVAERT | Correction: The Agfa-Gevaert Group in 2023: Group EBITDA increases by 52%, powered by its growth engines - regulated information | 50202025 Electronic Equipment: Gauges and Meters | Other subject |
13 Mar 2024 10:04 CET |
AGFA-GEVAERT | Correction: De Agfa-Gevaert Groep in 2023: EBITDA van de Groep 52% hoger, onder impuls van de groeimotoren - gereglementeerde informatie | 50202025 Electronic Equipment: Gauges and Meters | Other subject |
13 Mar 2024 09:18 CET |
SHURGARD | 20240304 Shurgard finalizes its transaction in German | 35101010 Real Estate Holding and Development | Mergers, Acquiqitions, Transferts |
13 Mar 2024 08:20 CET |
TITAN CEMENT | Résultats annuels 2023 | 50101030 Cement | Commercial results |
13 Mar 2024 08:19 CET |
TITAN CEMENT | Full Year Results 2023 | 50101030 Cement | Commercial results |
13 Mar 2024 07:45 CET |
AGFA-GEVAERT | The Agfa-Gevaert Group in 2023: Group EBITDA increases by 52%, powered by its growth engines - regulated information | 50202025 Electronic Equipment: Gauges and Meters | Other subject |
13 Mar 2024 07:45 CET |
AGFA-GEVAERT | Jeroen Spruyt appointed as President of Agfa’s Radiology Solutions division | 50202025 Electronic Equipment: Gauges and Meters | Other subject |
13 Mar 2024 07:45 CET |
AGFA-GEVAERT | De Agfa-Gevaert Groep in 2023: EBITDA van de Groep 52% hoger, onder impuls van de groeimotoren - gereglementeerde informatie | 50202025 Electronic Equipment: Gauges and Meters | Other subject |
13 Mar 2024 07:45 CET |
AGFA-GEVAERT | Jeroen Spruyt benoemd tot President van Agfa’s divisie Radiology Solutions | 50202025 Electronic Equipment: Gauges and Meters | Other subject |
13 Mar 2024 07:00 CET |
SOLVAY | Solvay fourth quarter and full-year 2023 results | 55201000 Chemicals: Diversified | Corporate life |
13 Mar 2024 07:00 CET |
SOLVAY | Résultats du quatrième trimestre et de l’année 2023 | 55201000 Chemicals: Diversified | Corporate life |
13 Mar 2024 07:00 CET |
SOLVAY | Solvay 2023 vierde kwartaal en jaarresultaten | 55201000 Chemicals: Diversified | Corporate life |
12 Mar 2024 18:21 CET |
BARCO | Transparency declaration by Norges Bank: Threshold crossed | 10102030 Computer Hardware | Share history |
12 Mar 2024 15:05 CET |
RECTICEL | Recticel kondigt baanbrekende samenwerking aan tussen Trimo en Pininfarina | 50203015 Plastics | Other subject |
12 Mar 2024 15:05 CET |
RECTICEL | Recticel announces landmark collaboration between Trimo and Pininfarina | 50203015 Plastics | Other subject |
12 Mar 2024 08:30 CET |
CIE BOIS SAUVAGE | Cie du Bois Sauvage: Terugkoop van eigen aandelen – Week van 04/03/2024 tot 08/03/2024 | 30202010 Asset Managers and Custodians | Other subject |
12 Mar 2024 08:30 CET |
CIE BOIS SAUVAGE | Cie du Bois Sauvage: Buy back of own shares – week from 04/03/2024 to 08/03/2024 | 30202010 Asset Managers and Custodians | Other subject |
12 Mar 2024 08:30 CET |
CIE BOIS SAUVAGE | Cie du Bois Sauvage : Rachat d’actions propres – semaine du 04/03/2024 au 08/03/2024 | 30202010 Asset Managers and Custodians | Other subject |
12 Mar 2024 08:00 CET |
KBC | KBC Groep: Update m.b.t. inkoopprogramma van KBC Groep voor eigen aandelen | 30101010 Banks | Other subject |
12 Mar 2024 08:00 CET |
KBC | KBC Group: Update regarding the KBC Group share buyback programme | 30101010 Banks | Other subject |
12 Mar 2024 08:00 CET |
KBC | KBC Groupe: Mise à jour concernant le programme de rachat d’actions propres de KBC Groupe | 30101010 Banks | Other subject |
12 Mar 2024 07:00 CET |
SYENSQO | Résultats de l'année 2023 de Syensqo | 55101000 Diversified Materials | Corporate life |
12 Mar 2024 07:00 CET |
BIOSENIC | BioSenic publie les détails de la stratégie d'administration optimisée pour OATO dans le traitement de la maladie chronique du greffon contre l'hôte en amont du prochain essai de phase 3 | 20103010 Biotechnology | Corporate life |
12 Mar 2024 07:00 CET |
SYENSQO | Resultaten Syensqo - jaar 2023 | 55101000 Diversified Materials | Corporate life |
12 Mar 2024 07:00 CET |
SYENSQO | Syensqo full-year 2023 results | 55101000 Diversified Materials | Corporate life |
12 Mar 2024 07:00 CET |
BIOSENIC | BioSenic releases details of optimized administration approach ahead of planned Phase 3 trial of OATO for chronic graft-versus-host disease | 20103010 Biotechnology | Corporate life |
12 Mar 2024 06:00 CET |
NYRSTAR | Nyrstar NV – Petition for interim measures received on 11 March 2024 | 55102050 Nonferrous Metals | Other subject |
12 Mar 2024 06:00 CET |
NYRSTAR | Nyrstar NV – Verzoekschrift voor voorlopige maatregelen ontvangen op 11 maart 2024 | 55102050 Nonferrous Metals | Other subject |
11 Mar 2024 18:09 CET |
GBL | GBL - Transacties op GBL-aandelen 11-03-2024 | 30202000 Diversified Financial Services | Other financial transaction |
11 Mar 2024 18:08 CET |
GBL | GBL - Transactions sur actions propres 11-03-2024 | 30202000 Diversified Financial Services | Other financial transaction |
11 Mar 2024 18:07 CET |
GBL | GBL - Transactions on GBL shares 11-03-2024 | 30202000 Diversified Financial Services | Other financial transaction |
11 Mar 2024 18:00 CET |
AZELIS GROUP NV | Azelis kondigt Aandeleninkoopprogramma 2024 aan onder zijn langetermijnstimulusplan | 55201000 Chemicals: Diversified | Other financial transaction |
11 Mar 2024 18:00 CET |
AZELIS GROUP NV | Azelis Launches Share Buyback Program 2024 under its Long-term Incentive Plan | 55201000 Chemicals: Diversified | Other financial transaction |
11 Mar 2024 08:35 CET |
TITAN CEMENT | Programme de rachats d'actions | 50101030 Cement | Other subject |
11 Mar 2024 08:35 CET |
TITAN CEMENT | Share buyback programme | 50101030 Cement | Other subject |
11 Mar 2024 07:30 CET |
ONWARD MEDICAL | ONWARD® Medical Accepted to New US FDA TAP Program for Development of its ARC-BCI™ System | 20101025 Health Services | - |